Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders
- PMID: 11232499
Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders
Abstract
Background: Cholestatic liver diseases are characterized by failure of normal amounts of physiological bile to reach the gastrointestinal tract. Any interference with normal bile flow from the canalicular membrane of the hepatocyte to the distal common bile duct may result in cholestasis.
Methods: Literature review.
Results: In primary biliary cirrhosis (PBC), the small intrahepatic bile ducts are destructed, resulting in obstruction of intrahepatic bile flow, whereas extrahepatic and/or intrahepatic biliary strictures block the passage of bile towards the intestine in primary sclerosing cholangitis (PSC). In contrast, the biliary tree is morphologically unaffected in less common cholestatic liver diseases as benign recurrent intrahepatic cholestasis (BRIC) and progressive familiar intrahepatic cholestasis (PFIC1-4). Genetic defects in hepatic canalicular transport mechanisms and bile salt synthesis deficiencies seem to underlie these types of cholestatic disorders.
Conclusion: Recent advances in understanding and treatment of cholestatic liver diseases may help in better diagnosing and treating the various conditions characterized by cholestasis.
Similar articles
-
Histopathology of cholestasis.Verh Dtsch Ges Pathol. 1995;79:233-40. Verh Dtsch Ges Pathol. 1995. PMID: 8600686 Review.
-
[Cholestatic liver diseases].Ther Umsch. 1997 Nov;54(11):639-44. Ther Umsch. 1997. PMID: 9454366 Review. German.
-
Variant forms of cholestatic diseases involving small bile ducts in adults.Am J Gastroenterol. 2000 May;95(5):1130-8. doi: 10.1111/j.1572-0241.2000.01999.x. Am J Gastroenterol. 2000. PMID: 10811317 Review.
-
Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.Ital J Gastroenterol. 1992 Jan;24(1):31-5. Ital J Gastroenterol. 1992. PMID: 1571577 Review.
-
[Intrahepatic cholestasis in chronic liver disease].Ann Ital Med Int. 1996 Oct;11 Suppl 2:48S-52S. Ann Ital Med Int. 1996. PMID: 9004820 Review. Italian.
Cited by
-
Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis.Hepatology. 2020 Oct;72(4):1461-1468. doi: 10.1002/hep.31430. Hepatology. 2020. PMID: 32583448 Free PMC article. Review. No abstract available.